Cargando…

Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure

BACKGROUND: Left ventricular ejection fraction (LVEF) is the most widely used parameter to evaluate the cardiac function in patients with heart failure (HF). However, the association between LVEF and contrast-induced nephropathy (CIN) is still controversial. Therefore, the aim of this study is to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kun, Li, Hua-long, Bei, Wei-jie, Guo, Xiao-sheng, Chen, Shi-qun, Islam, Sheikh Mohammed Shariful, Chen, Ji-yan, Liu, Yong, Tan, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529088/
https://www.ncbi.nlm.nih.gov/pubmed/28769566
http://dx.doi.org/10.2147/TCRM.S137654
_version_ 1783253074890981376
author Wang, Kun
Li, Hua-long
Bei, Wei-jie
Guo, Xiao-sheng
Chen, Shi-qun
Islam, Sheikh Mohammed Shariful
Chen, Ji-yan
Liu, Yong
Tan, Ning
author_facet Wang, Kun
Li, Hua-long
Bei, Wei-jie
Guo, Xiao-sheng
Chen, Shi-qun
Islam, Sheikh Mohammed Shariful
Chen, Ji-yan
Liu, Yong
Tan, Ning
author_sort Wang, Kun
collection PubMed
description BACKGROUND: Left ventricular ejection fraction (LVEF) is the most widely used parameter to evaluate the cardiac function in patients with heart failure (HF). However, the association between LVEF and contrast-induced nephropathy (CIN) is still controversial. Therefore, the aim of this study is to evaluate the association of LVEF with CIN and long-term mortality following coronary angiography (CAG) or intervention in patients with HF. METHODS: We analyzed 1,647 patients with HF (New York Heart Association [NYHA] or Killip class >1) undergoing CAG or intervention, including 207 (12.57%) patients with reduced LVEF (HFrEF), 238 (14.45%) with mid-range LVEF (HFmrEF) and 1,202 (72.98%) with preserved LVEF (HFpEF). CIN was defined as an absolute increase of ≥0.5 mg/dL or a relative increase of ≥25% from baseline serum creatinine within 48–72 h after contrast medium exposure. Multivariable logistic regression and Cox proportional hazards regression analyses were performed to identify the association between LVEF, CIN and long-term mortality, respectively. RESULTS: Overall, 225 patients (13.7%) developed CIN. Individuals with lower LVEF were more likely to develop CIN (HFrEF, HFmrEF and HFpEF: 18.4%, 21.8% and 11.2%, respectively; P<0.001), but without a significant trend after adjusting for the confounding factors (HFrEF vs HFpEF: odds ratio [OR] =1.01; HFmrEF vs HFpEF: OR =1.31; all P>0.05). However, advanced HF (NYHA class >2 or Killip class >1) was an independent predictor of CIN (adjusted OR =1.54, 95% confidence interval [CI], 1.07–2.22; P=0.019). During the mean follow-up of 2.3 years, reduced LVEF (HFrEF group) was significantly associated with increased mortality (HFrEF vs HFpEF: adjusted hazard ratio =2.88, 95% CI, 1.77–4.69; P<0.001). CONCLUSION: In patients with HF undergoing CAG or intervention, not worsened LVEF but advanced HF was associated with an increased risk of CIN. In addition, reduced LVEF was an independent predictor of long-term mortality following cardiac catheterization.
format Online
Article
Text
id pubmed-5529088
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55290882017-08-02 Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure Wang, Kun Li, Hua-long Bei, Wei-jie Guo, Xiao-sheng Chen, Shi-qun Islam, Sheikh Mohammed Shariful Chen, Ji-yan Liu, Yong Tan, Ning Ther Clin Risk Manag Original Research BACKGROUND: Left ventricular ejection fraction (LVEF) is the most widely used parameter to evaluate the cardiac function in patients with heart failure (HF). However, the association between LVEF and contrast-induced nephropathy (CIN) is still controversial. Therefore, the aim of this study is to evaluate the association of LVEF with CIN and long-term mortality following coronary angiography (CAG) or intervention in patients with HF. METHODS: We analyzed 1,647 patients with HF (New York Heart Association [NYHA] or Killip class >1) undergoing CAG or intervention, including 207 (12.57%) patients with reduced LVEF (HFrEF), 238 (14.45%) with mid-range LVEF (HFmrEF) and 1,202 (72.98%) with preserved LVEF (HFpEF). CIN was defined as an absolute increase of ≥0.5 mg/dL or a relative increase of ≥25% from baseline serum creatinine within 48–72 h after contrast medium exposure. Multivariable logistic regression and Cox proportional hazards regression analyses were performed to identify the association between LVEF, CIN and long-term mortality, respectively. RESULTS: Overall, 225 patients (13.7%) developed CIN. Individuals with lower LVEF were more likely to develop CIN (HFrEF, HFmrEF and HFpEF: 18.4%, 21.8% and 11.2%, respectively; P<0.001), but without a significant trend after adjusting for the confounding factors (HFrEF vs HFpEF: odds ratio [OR] =1.01; HFmrEF vs HFpEF: OR =1.31; all P>0.05). However, advanced HF (NYHA class >2 or Killip class >1) was an independent predictor of CIN (adjusted OR =1.54, 95% confidence interval [CI], 1.07–2.22; P=0.019). During the mean follow-up of 2.3 years, reduced LVEF (HFrEF group) was significantly associated with increased mortality (HFrEF vs HFpEF: adjusted hazard ratio =2.88, 95% CI, 1.77–4.69; P<0.001). CONCLUSION: In patients with HF undergoing CAG or intervention, not worsened LVEF but advanced HF was associated with an increased risk of CIN. In addition, reduced LVEF was an independent predictor of long-term mortality following cardiac catheterization. Dove Medical Press 2017-07-19 /pmc/articles/PMC5529088/ /pubmed/28769566 http://dx.doi.org/10.2147/TCRM.S137654 Text en © 2017 Wang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Wang, Kun
Li, Hua-long
Bei, Wei-jie
Guo, Xiao-sheng
Chen, Shi-qun
Islam, Sheikh Mohammed Shariful
Chen, Ji-yan
Liu, Yong
Tan, Ning
Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
title Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
title_full Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
title_fullStr Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
title_full_unstemmed Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
title_short Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
title_sort association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529088/
https://www.ncbi.nlm.nih.gov/pubmed/28769566
http://dx.doi.org/10.2147/TCRM.S137654
work_keys_str_mv AT wangkun associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT lihualong associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT beiweijie associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT guoxiaosheng associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT chenshiqun associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT islamsheikhmohammedshariful associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT chenjiyan associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT liuyong associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure
AT tanning associationofleftventricularejectionfractionwithcontrastinducednephropathyandmortalityfollowingcoronaryangiographyorinterventioninpatientswithheartfailure